Key laboratory diagnostic biomarkers of coronary atherosclerosis

Kardiologiya

Volumn 51, Issue 3, 2011, Pages 42-46

  Ragino, Yu L ^a   Chernjavski, A M ^a   Eremenko, N V ^a   Shakhtshneider, E V ^a   Polonskaya, Ya V ^a   Tsimbal, S Yu ^a   Ivanova, M V ^a   Voevoda, M I ^a  

^a Institute of Therapy   (Russian Federation)

Author keywords

Coronary atherosclerosis; Inflammation; Lipid and carbohydrate biomarkers; Oxidation; Population study

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD; CORONARY ARTERY DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; RUSSIAN FEDERATION; STATISTICAL ANALYSIS;

AGED; ANTIOXIDANTS; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; DATA INTERPRETATION, STATISTICAL; HUMANS; INSULIN; LIPID PEROXIDATION; MALE; MIDDLE AGED; RISK FACTORS; SIBERIA; TRIGLYCERIDES;

EID: 79960955096     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Nikitin Yu., Malyutina S. MONICA. Monograph and Multimedia Sourcebook. World.s largest study of heart disease, stroke, risk factors, and population trends 1979-2002. Edited by Hugh Tunstall-Pedoe (with 64 other contributors for the WHO MONICA Project). WHO, Geneva 2003;237.
2. Steinberg D. The LDL modification hypothesis of atherogenesis: an update. J Lipid Res 2009; Suppl: S376-S381.
3. Steinberg D. Hypercholesterolemia and inflammation in atherogenesis: two sides of the same coin. Mol Nutr Food Res 2005;49:995-998.
4. Stocker R., Keaney J. F. New insights on oxidative stress in the artery wall. J Thromb Haemost 2005;3:1825-1834.
5. Tabet F., Rye K. A. High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 2009;116:87-98.
6. Fruchart J.-C. Pathophysiology of stages of development of atherosclerosis. Handbook of dyslipidemia and atherosclerosis. France, University of Lille 2003;1:1-65.
7. Nitenberg A., Cosson E., Pham I. Postprandial endothelial dysfunction: role of glucose, lipids and insulin. Diabetes Metab 2006;32:2S28-2S33.
8. Armstrong E. J., Morrow D. A., Sabatine M. S. Inflammatory biomarkers in acute coronary syndromes: part I: introduction and cytokines. Circulation 2006;113:e72-75.
9. Armstrong E. J., Morrow D. A., Sabatine M. S. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation 2006;113:e382-385.
10. Bucova M., Bernadic M., Buckingham T. C-reactive protein, cytokines and inflammation in cardiovascular diseases. Bratisl Lek Listy 2008;109:333-340.
11. Pearson T. A., Mensah G. A., Alexander R. W. et al. Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
12. Sukhija R., Fahdi I., Garvx L. et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007;99:879-884.
13. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary the task force on diabetes and cardiovascular diseases of the European society of cardiology and of the European association for the study of diabetes. Eur Heart J 2007;28:88-136.
14. Klein S., Allison D. B., Heymsfield S. B. et al. Waist circumference and cardiornetabolic risk: a consensus statement from Shaping America's Health: Association for weight management and obesity prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association (ADA). Diabetes Care 2007;30:1647-1652.
15. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008;31:1283-1292.
16. Grundy S. M., Cleeman J. I., Daniels S. R. et al. Diagnosis and management of the metabolic syndrome: a statement for health care professionals: an American Heart Association/National Heart, Lung and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752.